MedPath

Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis

Not Applicable
Completed
Conditions
Multiple Sclerosis (MS)
Interventions
Behavioral: Physical activity behavioral intervention in persons newly diagnosed with MS
Registration Number
NCT05641532
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This single group pre-post pilot intervention will examine the feasibility and initial effect of a 12-week behavioral intervention, based on the Behavior Change Wheel and Capability-Opportunity-Motivation-Behavior (COM-B) model and remotely delivered through electronic newsletters and online one-on-one video conferencing, for promoting physical activity and secondarily reducing fatigue and quality of life in persons newly diagnosed with MS (diagnosed with MS within the past 2 years). The investigators hypothesize the proposed 12-week intervention will be feasible based on process, resource, management, and scientific outcomes. The investigators further hypothesize that individuals who receive the 12-week intervention will demonstrate an increase in physical activity behavior, particularly daily step counts, and reduce fatigue.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • ≥ 18 years old
  • Diagnosed with multiple sclerosis for 2 or fewer years
  • Fully ambulatory
  • No relapse within the last 30 days
  • Non-active (Godin Leisure-Time Exercise Questionnaire - Health Contribution Score < 14)
  • Able to read 14-point font size
  • Internet & video conferencing access
  • Undergoing disease-modifying therapy
Exclusion Criteria
  • Pregnancy
  • Moderate or high risk for undertaking physical activity (≥ 2 affirmatives on the Physical Activity Readiness Questionnaire)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Capability-Opportunity-Motivation-Behavior (COM-B) based physical activity behavioral interventionPhysical activity behavioral intervention in persons newly diagnosed with MSThis is a 1-arm study with an intervention condition based on the COM-B model
Primary Outcome Measures
NameTimeMethod
Feasibility metric: Process12 weeks

Process assesses participant recruitment, retention, and adherence i. Recruitment and refusal rates ii. Retention, attrition, and adherence rates to study procedures

Feasibility metric: Management12 weeks

Management assesses data management.

Feasibility metric: Overall safety12 weeks

Overall safety will be assessed through the number of adverse events.

Feasibility metric: Resource12 weeks

We will assess the resources required for the study.

Change of Physical Activity levels through the Abbreviated International Physical Activity Questionnaire from baseline and 12 weeks12 weeks

Physical activity will be assessed using the Abbreviated International Physical Activity Questionnaire. Participants will complete this questionnaire at baseline and 12 weeks.

Change of Physical Activity levels through Accelerometry from baseline and 12 weeks12 weeks

Physical activity will be assessed using an ActiGraph accelerometer. Participants will wear an accelerometer on a belt around their waist during the waking hours of a 7 day period. Participants will complete this at baseline and 12 weeks

Change of Physical Activity levels through the Godin Leisure-Time Exercise Questionnaire from baseline and 12 weeks12 weeks

Physical activity will be assessed using the Godin Leisure-Time Exercise Questionnaire. Participants will complete this questionnaire at baseline and 12 weeks.

Secondary Outcome Measures
NameTimeMethod
Changes of self-report measures of quality of life through the Multiple Sclerosis Impact Scale-29 at baseline and 12 weeks12 weeks

Self report measures of quality of life will be assessed through the Multiple Sclerosis Impact Scale-29.Participants will complete this questionnaire at baseline and 12 weeks

Change of self-report measures of Fatigue through the Fatigue Severity Scale from baseline and 12 weeks12 weeks

Self report measures of fatigue will be assessed through the Fatigue Severity Scale. Participants will complete this questionnaire at baseline and 12 weeks

Formative evaluation12 weeks

Participants' satisfaction in the study will be assessed through a self-developed survey which will be completed at 12 week.

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath